SGLT2 inhibitors may worsen heart failure outcomes from chemotherapy, highlighting the need for further long-term studies on cardiotoxicity, explains Rakendu Rajendran, MBBS. At the ASPC 2025 Congress ...
MedPage Today on MSN
Kate Middleton's Chemo; SGLT2 Inhibitors and Prostate Cancer; New Myeloma Guidance
The novel MEK inhibitor atebimetinib in combination with modified gemcitabine/nab-paclitaxel led to a 12-month overall ...
Controversies in the Treatment of Urothelial Carcinoma Learn more about the therapeutic options available for invasive bladder cancer -- and which patient characteristics may influence treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback